Andrea Morotti, MD; Andreas Charidimou, MD, PhD; Chia-Ling Phuah, MD; et al.
free access
JAMA Neurol. 2016;73(11):1285-1290. doi:10.1001/jamaneurol.2016.2252
This cohort study investigates whether a low serum calcium level is associated with an increase in the extent of bleeding in patients with intracerebral hemorrhage as measured by baseline hematoma volume and risk of hematoma expansion.
Amrou Sarraj, MD; Navdeep Sangha, MD; Muhammad Shazam Hussain, MD; et al.
free access
JAMA Neurol. 2016;73(11):1291-1296. doi:10.1001/jamaneurol.2016.2773
This pooled cohort study evaluates the safety and effectiveness of endovascular therapy for occlusions of the M2 segment of the middle cerebral artery in patients with ischemic stroke.
Boyan Fang, MD, PhD; Andrew McKeon, MD; Shannon R. Hinson, PhD; et al.
free access
has audio
JAMA Neurol. 2016;73(11):1297-1307. doi:10.1001/jamaneurol.2016.2549
This study describes a novel IgG autoantibody found in serum or cerebrospinal fluid that is specific for a cytosolic intermediate filament protein of astrocytes.
-
Podcast:
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy (JAMA Neurology)
Pashtun Shahim, MD, PhD; Yelverton Tegner, MD, PhD; Bengt Gustafsson, MD; et al.
free access
JAMA Neurol. 2016;73(11):1308-1315. doi:10.1001/jamaneurol.2016.2038
This study investigates whether persistent symptoms after mTBI are associated with brain injury as evaluated by cerebrospinal fluid biochemical markers for axonal damage and other aspects of central nervous system injury.
Xiao-Yan Qin, MD; Shu-Ping Zhang, PhD; Chang Cao, BS; et al.
free access
JAMA Neurol. 2016;73(11):1316-1324. doi:10.1001/jamaneurol.2016.2742
This meta-analysis quantitatively summarizes data on peripheral inflammatory cytokines in patients with Parkinson disease.
Jinte Middeldorp, PhD; Benoit Lehallier, PhD; Saul A. Villeda, PhD; et al.
free access
JAMA Neurol. 2016;73(11):1325-1333. doi:10.1001/jamaneurol.2016.3185
This preclinical study determines whether young blood plasma ameliorates pathology and cognition in a mouse model for AD.
Stephen N. Gomperts, MD, PhD; Joseph J. Locascio, PhD; Sara J. Makaretz, BS; et al.
free access
JAMA Neurol. 2016;73(11):1334-1341. doi:10.1001/jamaneurol.2016.3338
This cross-sectional study examines the use of positron emission tomographic imaging in patients with dementia of Lewy bodies and Parkinson disease, with and without cognitive impairment, for determination of neocortical tau pathology.
Valentina Damato, MD; Amelia Evoli, MD; Raffaele Iorio, MD, PhD
free access
JAMA Neurol. 2016;73(11):1342-1348. doi:10.1001/jamaneurol.2016.1637
This systematic review and meta-analysis evaluates the efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders, considering the potential predictive factors related to patient response to rituximab in this disease.